Skip to menu Skip to content Skip to footer
Dr Christine Staatz
Dr

Christine Staatz

Email: 
Phone: 
+61 7 334 61974

Overview

Background

Christine graduated with a Bachelor of Pharmacy degree (honours class 1) from the University of Queensland in 1996.

She registered as a pharmacist in Australia in 1997 and in the United Kingdom in 2003 and has worked at the Redlands, Princess Alexandra and Wesley Hospitals in Brisbane and the Western Infirmary in Glasgow. In 2002 she was awarded a PhD from the University of Queensland, with a thesis focusing on improving usage of the immunosuppressant agent tacrolimus in solid organ transplant recipients.

In 2004 she was the recipient of a National Health and Medical Research Council (NHMRC) Neil Hamilton Fairley fellowship. This award enabled her to training overseas in the field of Pharmacometrics within the Department of Medicine and Therapeutics at the University of Glasgow (Scotland) and the Department of Pharmaceutical Biosciences at Uppsala University (Sweden).

On her return to Brisbane, Christine was the recipient of a Lions Medical Research Fellowship and was the chief investigator on a three year NHMRC Project Grant. She has also been a team member on an Amgen-Transplant Society of Australia and New Zealand Research Grant and a Cellcept Australia Research Grant. Over her research career Christine has attracted grants and awards totaling more than 2 million AUD from various funding agencies.

Research Interests

Christine has a wide range of interests in the fields of Quality Use of Medicine and Pharmacometrics. Her work to date has primarily been directed towards optimising usage of immunosuppressant drugs in solid organ transplant recipients and antibiotics in patients with life-threatening infections.

Christine has published over 75 peer reviewed papers and 90 conference abstracts on these topics. Her publications have been cited on more than 3200 occasions, with twelve cited more than 50 times.

Christine has successfully supervised to completion fourteen higher research degree students and enjoys helping students meet their career goals.

Christine’s current projects include:

  • Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
  • Comparing the efficacy and safety of continuous versus intermittent administration of beta-lactams in critically ill patients
  • Examining the relationship between immunosuppression and non-melanoma skin cancer in renal transplant recipients
  • Improving individualisation of immunosuppressant therapy in adult kidney transplant recipients
  • Improving gentamycin dosing in paediatric oncology patients
  • Examining tobramycin monitoring in cystic fibrosis patients in Australia and the United Kingdom
  • Investigating the relationship between prednisolone exposure and drug-related toxicity in paediatric and adult kidney transplant recipients
  • Comparing different therapeutic drug monitoring methods for dosage adjustment of once daily intravenous tobramycin treatment in children with cystic fibrosis

Projects currently available for interested research higher degree students include:

  • Dose optimisation of busulfan in paediatric bone marrow transplant recipients
  • Investigating the relationship between immunosupressant exposure and drug-related toxicity in transplant recipients
  • Examining Bayesian forecasting methods to predict immunosuppressant exposure
  • Examining the international use of immunosuppressant and anti-rheumatic drugs
  • Examining the influence of plasma exchange on immunosuppressant drug exposure

Christine invites potential honours and post-graduate students to contact her via email to discuss research opportunities.

Teaching interests

Co-ordinates:

  • PHRM3052- Biological Fate of Drugs

Teaches in:

  • PHRM3052- Biological Fate of Drugs
  • PHRM3011- Quality Use of Medicines

Availability

Dr Christine Staatz is:
Available for supervision

Qualifications

  • Bachelor, The University of Queensland
  • Bachelor (Honours) of Pharmacy, The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Works

Search Professor Christine Staatz’s works on UQ eSpace

254 works between 1998 and 2025

201 - 220 of 254 works

2010

Conference Publication

Evaluation of limited sampling strategies for simultaneous estimation of tacrolimus, mycophenolic acid and prednisolone exposure in adult kidney transplant recipients

Barraclough, K. A., Isbel, N. M., Johnson, D. W., Medley, G., Lee, K. J., Leary, D. R., Campbell, S. B. and Staatz, C. E. (2010). Evaluation of limited sampling strategies for simultaneous estimation of tacrolimus, mycophenolic acid and prednisolone exposure in adult kidney transplant recipients. XXIII International Congress of the Transplant Society, Vancouver Canada, 15-19 August 2010.

Evaluation of limited sampling strategies for simultaneous estimation of tacrolimus, mycophenolic acid and prednisolone exposure in adult kidney transplant recipients

2010

Conference Publication

Sparse sampling strategies for monitoring of mycophenolic acid following mycophenolate mofetil intake in adult renal transplant recipients.

Barraclough, K. A., Isbel, N. M., Franklin, Michael, Lee, Katie, Taylor, Paul, Campbell, Scott, Johnson, David, Petchey, William and Staatz, Christine (2010). Sparse sampling strategies for monitoring of mycophenolic acid following mycophenolate mofetil intake in adult renal transplant recipients.. TSANZ Annual Scientific Meeting, Canberra, 23-25 June 2010. Australia: Nature Publishing Group.

Sparse sampling strategies for monitoring of mycophenolic acid following mycophenolate mofetil intake in adult renal transplant recipients.

2009

Journal Article

Population pharmacokinetics of tacrolimus in pediatric hematopoietic stem cell transplant recipients: New initial dosage suggestions and a model-based dosage adjustment tool

Wallin, Johan E., Friberg, Lena E., Fasth, Anders and Staatz, Christine E. (2009). Population pharmacokinetics of tacrolimus in pediatric hematopoietic stem cell transplant recipients: New initial dosage suggestions and a model-based dosage adjustment tool. Therapeutic Drug Monitoring, 31 (4), 457-466. doi: 10.1097/FTD.0b013e3181aab02b

Population pharmacokinetics of tacrolimus in pediatric hematopoietic stem cell transplant recipients: New initial dosage suggestions and a model-based dosage adjustment tool

2009

Journal Article

A comparison of mycophenolate use in Australia and Northern Europe, and the impact on the pharmaceutical benefits scheme

Staatz, Christine E., Smith, Alesha J. and Tett, Susan E. (2009). A comparison of mycophenolate use in Australia and Northern Europe, and the impact on the pharmaceutical benefits scheme. Pharmacoepidemiology and drug safety, 18 (5), 386-392. doi: 10.1002/pds.1726

A comparison of mycophenolate use in Australia and Northern Europe, and the impact on the pharmaceutical benefits scheme

2009

Journal Article

Therapeutic monitoring of mycophenolate in transplantation: Is it justified?

Barraclough, K.A., Staatz, C.E., Isbel, N.M. and Johnson, D.W. (2009). Therapeutic monitoring of mycophenolate in transplantation: Is it justified?. Current Drug Metabolism, 10 (2), 179-187. doi: 10.2174/138920009787522205

Therapeutic monitoring of mycophenolate in transplantation: Is it justified?

2009

Conference Publication

Evaluating the predictive performance of a population pharmacokinetic model of tacrolimus using a validation dataset based on sparse, adaptive-design data

Wallin, J. E., Bergstrand, M., Karlsson, M. O., Wilczek, H. and Staatz, Christine E. (2009). Evaluating the predictive performance of a population pharmacokinetic model of tacrolimus using a validation dataset based on sparse, adaptive-design data. PKUK Conference 2009, Birmingham, United Kingdom, 25-27 November 2009. Birmingham, U.K.: Pharmacokinetics UK.

Evaluating the predictive performance of a population pharmacokinetic model of tacrolimus using a validation dataset based on sparse, adaptive-design data

2009

Journal Article

Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations

Thomson, A. H., Staatz, C. E., Tobin, C. M., Gall, M. and Lovering, A. M. (2009). Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations. Journal of Antimicrobial Chemotherapy, 63 (5), 1050-1057. doi: 10.1093/jac/dkp085

Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations

2008

Conference Publication

Comparisons of mycophenolate usage in Northern European and Australian transplant populations

Smith, Alesha, Staatz, Christine E. and Tett, Susan E. (2008). Comparisons of mycophenolate usage in Northern European and Australian transplant populations. 9th World Conference on Clinical Pharmacology and Therapeutics, Quebec, Canada, 27 July - 1 August 2008. Oakville, ON, Canada: Pulsus Group.

Comparisons of mycophenolate usage in Northern European and Australian transplant populations

2008

Conference Publication

Individualisation of immunosuppressant drugs in organ transplantation - research to improve patient outcomes

Staatz, Christine E. (2008). Individualisation of immunosuppressant drugs in organ transplantation - research to improve patient outcomes. Australian Health and Medical Research Congress (AHMRC) 2008, Brisbane, Australia, 16-21 November 2008. Sydney, Australia: AHMRC.

Individualisation of immunosuppressant drugs in organ transplantation - research to improve patient outcomes

2008

Conference Publication

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplant recipients

Wallin, Johan E., Friberg, Lena E. and Staatz, Christine E. (2008). Population pharmacokinetics of tacrolimus in paediatric bone marrow transplant recipients. Annual Meeting of the Population Approach Group in Europe, Marseille, France, 18-20 June 2008.

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplant recipients

2008

Conference Publication

Tracking of gentamicin and vancomycin in ICU patients - evaluation of multiple model (SMM and RMM) versus interacting multiple model (IMM) Bayesian fitting

Macdonald, I., Staatz, Christine E., Jelliffe, R. W. and Thomson, A..H. (2008). Tracking of gentamicin and vancomycin in ICU patients - evaluation of multiple model (SMM and RMM) versus interacting multiple model (IMM) Bayesian fitting. 15th Russian National Congress "Man and Drugs", Moscow, Russia, 14-18 April 2008.

Tracking of gentamicin and vancomycin in ICU patients - evaluation of multiple model (SMM and RMM) versus interacting multiple model (IMM) Bayesian fitting

2008

Conference Publication

Early calcineurin inhibitor and mycophenolate mofetil exposure and acute rejection and drug toxicity after renal transplantation

Brooks, E. K., Johnson, D. W., Staatz, Christine E., Taylor, P. J. and Tett, Susan E. (2008). Early calcineurin inhibitor and mycophenolate mofetil exposure and acute rejection and drug toxicity after renal transplantation. Australian Health and Medical Research Congress (AHMRC) 2008, Brisbane, Australia, 16-21 November 2008. Sydney, Australia: AHMRC.

Early calcineurin inhibitor and mycophenolate mofetil exposure and acute rejection and drug toxicity after renal transplantation

2008

Conference Publication

Pattern of mycophenolate prescribing in Australian kidney and cardiac transplant recipients

Staatz, Christine E., Smith, Alesha and Tett, Susan E. (2008). Pattern of mycophenolate prescribing in Australian kidney and cardiac transplant recipients. National Medicines Symposium 2008, Canberra, 14-16 May 2008.

Pattern of mycophenolate prescribing in Australian kidney and cardiac transplant recipients

2008

Journal Article

Evaluation and comparison of simple multiple model, richer data multiple model, and sequential interacting multiple model (IMM) Bayesian analyses of Gentamicin and Vancomycin data collected from patients undergoing cardiothoracic surgery

Macdonald, I., Staatz, C. E., Jelliffe, R. W. and Thomson, A. H. (2008). Evaluation and comparison of simple multiple model, richer data multiple model, and sequential interacting multiple model (IMM) Bayesian analyses of Gentamicin and Vancomycin data collected from patients undergoing cardiothoracic surgery. Therapeutic Drug Monitoring, 30 (1), 67-74. doi: 10.1097/FTD.0b013e318161a38c

Evaluation and comparison of simple multiple model, richer data multiple model, and sequential interacting multiple model (IMM) Bayesian analyses of Gentamicin and Vancomycin data collected from patients undergoing cardiothoracic surgery

2008

Conference Publication

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dosage adaption tool

Wallin, Johan E., Friberg, L.E, Fasth, A and Staatz, Christine E. (2008). Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dosage adaption tool. ImmunoTDM Warsaw 2008: International Conference Therapeutic Drug Monitoring in Optimizing the Immunosuppressive Therapy, Warsaw, Poland, 26-27 September 2008. Warszawa, Poland: Institute of Transplantation Sciences, Medical University of Warsaw.

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dosage adaption tool

2007

Conference Publication

Comparison of different diagnostic criterion to evaluate nonlinear mixed-effects models

Staatz, Christine E., Karlsson, Mats O. and Hooker, Andrew (2007). Comparison of different diagnostic criterion to evaluate nonlinear mixed-effects models. Population Approach Group in Australia & New Zealand, Singapore, 13 - 15 February 2007. Singapore: PAGJA/PAGANZ.

Comparison of different diagnostic criterion to evaluate nonlinear mixed-effects models

2007

Conference Publication

Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period

Staatz, Christine, Wong, Jenny, Taylor, Paul, Johnson, David and Tett, Susan (2007). Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period. 10th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, Nice, France, 9-14 September, 2007. New York: Lippincott-Raven. doi: 10.1097/FTD.0b013e31813797e8

Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period

2007

Journal Article

Predictors of new onset diabetes after renal transplantation

Joss, N., Staatz, C. E., Thomson, A. and Jardine, A. (2007). Predictors of new onset diabetes after renal transplantation. Clinical Transplantation, 21 (1), 136-143. doi: 10.1111/j.1399-0012.2006.00580.x

Predictors of new onset diabetes after renal transplantation

2007

Journal Article

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients

Staatz, Christine E. and Tett, Susan E. (2007). Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clinical Pharmacokinetics, 46 (1), 13-58. doi: 10.2165/00003088-200746010-00002

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients

2007

Journal Article

Conditional weighted residuals (CWRES): A model diagnostic for the FOCE method

Hooker, Andrew C., Staatz, Christine E. and Karlsson, Mats O. (2007). Conditional weighted residuals (CWRES): A model diagnostic for the FOCE method. Pharmaceutical Research, 24 (12), 2187-2197. doi: 10.1007/s11095-007-9361-x

Conditional weighted residuals (CWRES): A model diagnostic for the FOCE method

Funding

Current funding

  • 2024 - 2026
    Exploring the impact of BUsulfan METabolites on busulfan clearance, exposure and patient outcomes following Haematopoietic Stem Cell Transplantation (BU-MET-HSCT). (QHCRF administered by CHQ HHS)
    Children's Health Queensland Hospital and Health Service
    Open grant

Past funding

  • 2019 - 2020
    Evaluating immunosuppressant medicines in elderly renal transplant recipients
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2019
    Bu4DayPK - Analysis of once daily IV Busulfan in paediatric HSCT patients
    Children's Health Queensland Hospital and Health Service
    Open grant
  • 2018 - 2019
    Innovative blood sampling to reduce the burden of long-term treatment for kidney transplant recipients
    Metro North Hospital and Health Service
    Open grant
  • 2014
    Designing optimal dosing regimens for immunosuppressant medications
    Queensland Pharmacy Research Trust
    Open grant
  • 2010 - 2011
    Examining the relationship between immunosuppression and BK virus infection in adult kidney transplant recipients
    UQ New Staff Research Start-Up Fund
    Open grant
  • 2010
    Analytical instrumentation enabling rapid compound separation and chemical structure analysis via mass fingerprinting
    UQ Major Equipment and Infrastructure
    Open grant
  • 2008 - 2011
    Lions Medical Research Foundation Fellowship - Tailoring doses of the newer immunosuppressant drugs to improve outcomes after transplant
    Lions Medical Research Foundation
    Open grant
  • 2008 - 2011
    Improved patient outcomes through dosage individualisation of the newer immunosuppressant drugs
    NHMRC Project Grant
    Open grant
  • 2008
    UQ Travel Awards Category 2 - Christine Staatz
    UQ Travel Grants Scheme
    Open grant
  • 2004 - 2008
    NEIL HAMILTON FAIRLEY FELLOWSHIP: Population Pharmacokinetic And Pharmacodynamic Modelling Of The Newer Immunosuppressant Drugs
    NHMRC Training (Postdoctoral) Fellowship
    Open grant

Supervision

Availability

Dr Christine Staatz is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Dr Christine Staatz's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au